Equities analysts expect Titan Medical Inc. (NASDAQ:TMDI) to report earnings of ($0.64) per share for the current quarter, according to Zacks. Zero analysts have provided estimates for Titan Medical’s earnings, with the highest EPS estimate coming in at ($0.55) and the lowest estimate coming in at ($0.73). Titan Medical reported earnings per share of $0.43 during the same quarter last year, which indicates a negative year-over-year growth rate of 248.8%. The company is expected to announce its next quarterly earnings results on Monday, August 12th.
According to Zacks, analysts expect that Titan Medical will report full year earnings of ($2.89) per share for the current fiscal year. For the next fiscal year, analysts anticipate that the company will report earnings of ($1.26) per share. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research firms that follow Titan Medical.
TMDI has been the topic of a number of recent analyst reports. Maxim Group reissued a “buy” rating and issued a $8.00 price objective on shares of Titan Medical in a research note on Thursday, February 14th. Zacks Investment Research raised Titan Medical from a “sell” rating to a “hold” rating in a research note on Thursday, February 28th. Finally, Piper Jaffray Companies began coverage on Titan Medical in a research note on Wednesday, May 22nd. They issued an “overweight” rating and a $6.00 price objective on the stock.
Shares of NASDAQ TMDI opened at $2.16 on Tuesday. Titan Medical has a one year low of $1.05 and a one year high of $7.75. The stock has a market cap of $47.03 million and a price-to-earnings ratio of -1.59.
An institutional investor recently bought a new position in Titan Medical stock. Pathlight Investors LLC acquired a new stake in Titan Medical Inc. (NASDAQ:TMDI) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 16,439 shares of the company’s stock, valued at approximately $39,000. Pathlight Investors LLC owned 0.12% of Titan Medical as of its most recent SEC filing. Institutional investors own 13.14% of the company’s stock.
About Titan Medical
Titan Medical Inc, a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures.
Recommended Story: Balanced Fund
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.